Home » Reports » Broker Ratings » Oxford BioMedica plc 49.4% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc 49.4% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc with EPIC/TICKER (LON:OXB) has had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘BUY’ today by analysts at Liberum Capital. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Liberum Capital have set a target price of 810 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 49.4% from today’s opening price of 542 GBX. Over the last 30 and 90 trading days the company share price has decreased 79 points and decreased 185 points respectively. The 52 week high for the share price is currently at 925.1 GBX while the 52 week low for the share price is 461.5 GBX.

Oxford BioMedica plc has a 50 day moving average of 644.88 GBX and a 200 Day Moving Average share price is recorded at 691.25. There are currently 76,767,971 shares in issue with the average daily volume traded being 87,315. Market capitalisation for LON:OXB is £417,517,960 GBP.